Market Size
The Global Pharmaceutical Plastic Bottle Market was valued at USD 22.6 Billion in 2025 and is projected to reach USD 36.8 Billion by 2033, growing at aCAGR of 5.0% during the forecast period (2026-2033).
Plastic bottles are lightweight and simpler to use as packaging material in pharmaceutical uses. The adoption of these bottles is developing. Manufacturers favor the utilization of plastic bottles because of lower creation costs and an assortment of developments. Manufacturers are mindful of ecological issues and unsafe impacts as bottles are utilized in the drug business.
Moreover, the regulatory bodies are taking care of the inventory network of drug items that need exceptional packaging conditions because of their sensitive nature. As a result, this makes it basic for drug producers to follow rigid necessities to secure customer well-being and natural guidelines.
Source: DataM Intelligence Analysis (2021)
Market Dynamics
Cost-effective and durability make plastic more efficient packing materials than paper, glass and metal. However, stringent environmental regulations by the government and regulatory bodies are likely to hinder the market.
The cost-effective and durability make plastic more efficient packing materials than its counterparts like paper, glass and metal
Plastic is among the most utilized packaging materials than paper, glass and metal. The minimal expense of packaging is driving its utilization in the drug business. Therefore, the major players have expanded their interests in innovative work to handle ecological concerns and make plastic containers more secure for drug use. The introduction of child-resistant closures is one of the key innovative headways that has expanded the development of the business. The child-resistant closures come in the two-piece push and turn pieces for the most part.
Also, reusing is enlarging the development of plastic bottles in the drug business. Plastic bottles have consistently been the favored method of packaging tablets and containers. The bottles are likewise utilized for packaging fluid measurements, similar to syrups, nasal and ophthalmic meds. The benefit of a plastic container is that drug producers can put more tablets in bottles more proficiently and cost-adequately.
Amcor Limited developed a special bottle for the patients' comfort that gives additional data about the medication and its applications to assist patients with setting up a cell phone suggestion to take their measurements. In addition, it permits patients to examine each portion so consistency can be observed help medical services suppliers get ready follow-on solutions in the wake of actually taking a look at doses.
Stringent environmental regulation by the government and regulatory bodies are likely to hinder the market
The global market for a pharmaceutical bottles is expected to be restrained by rising concerns about the dumping of plastic packaging products and government regulations governing plastic packaging products. Some types of plastic, such as polyethylene terephthalate, are being recycled due to technological breakthroughs.
Segment Analysis
Based on raw material, the global pharmaceutical plastic bottle market is segmented into polyethylene terephthalate (PET), low-density polyethylene (LDPE), high-density polyethylene (HDPE) and others.
HPDE is a polyethylene thermoplastic produced using petrol. It is to a great extent known for its solidarity to-thickness proportion and has a significant application in plastic container creation. HDPE bottles offer minimal expanding capacities, giving them more grounded intermolecular powers and superior rigidity than LDPE. Furthermore, HPDE is harder, murkier and can withstand higher temperatures of the request for 110 Celsius. Polypropylene is a different polymer produced using monomer propylene. The polymer is rough and abnormally impervious to numerous compound solvents, bases and acids.
The expansion in the income of drugs will fundamentally prompt HDPE's interest. The convenience and popularity of plastic jugs are relied upon to help the pharmaceutical plastic bottle market develop moderately over the forecast period.
Source: DataM Intelligence Analysis (2021)
Geographical Analysis
The global pharmaceutical plastic bottle market is segmented into North America, Europe, South America, Asia-Pacific, and Middle East & Africa based on geography.
The drug business is one of the major supporters of plastic containers in North America. Purchasers are becoming more well-being cognizant, there are more well-being check-ups and the interest for plastic jugs will ascend in the conjecture time frame. Drugs put away in bottles are being ensured through different sorts of sealed shut plastic bottles.
The bottles are being utilized in mass and solution portion packaging of oral moral medications and substantial portion oral over-the-counter drugs in enormous amounts. Also, stringent guidelines, expanding requests in the end-client industry and the developing socioeconomics preferring savvy arrangements are a few variables enlarging the market's development.
The companies in North America are hoping to venture into developing business sectors, with no refined cold stockpiling chains and delivering a package that can give a longer period of usability. For example, in March 2021, Gerresheimer AG, the main drug plastic jug producer, began developing and improving its new assembling office in Ohio, U.S. Likewise, the office will create plastic containers for strong, fluid and ophthalmic/nasal details.
Source: DataM Intelligence Analysis (2021)
Competitive Landscape
The global pharmaceutical plastic bottle market is highly competitive with several end-use industries, resulting in high investment by multinational and local companies, contributing to the major share in the market growth. In addition, major players contributing to the market's growth are Amcor Limited, Berry Global, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging, Alpack Plastic Packaging, O. Berk Company, LLC., Pont Europe Limited, Drug Plastics Group and others. The companies adopt growth strategies such as expansions, acquisitions, product launches and collaborations, contributing to the market growth globally.
Berry Global, Inc.
Overview: Berry Global, Inc. is a global U.S.-based manufacturer of plastic packaging products. The company is headquartered in Evansville, Indiana. Berry Global, Inc. operates primarily in three divisions: Health, Hygiene, Specialties, Consumer Packaging and Engineered Materials. In addition, the company has a global presence with over 290 facilities across the globe and more than 48,000 employees.
Product Portfolio: Berry Global, Inc. offers complete prescription vials in pharmaceutical packaging with oval bottles, prescription vials and ointment jars. In addition, the company designs costumed products.
Key Development:
- On February 22, 2026, Amcor plc announced the expansion of its pharmaceutical packaging portfolio with next-generation recyclable plastic bottle solutions designed for oral solid dose and liquid drug formulations. The development focuses on improving barrier properties, child-resistant features, and sustainability compliance in response to tightening pharmaceutical packaging regulations.
- On December 5, 2025, Gerresheimer AG launched an advanced lightweight pharmaceutical plastic bottle line aimed at reducing material usage while maintaining drug stability and safety standards. The innovation supports growing demand for eco-friendly and patient-centric packaging solutions in the global healthcare sector.
- On September 18, 2025, Berry Global Inc. expanded its pharmaceutical packaging manufacturing capacity in North America to meet rising demand for high-quality HDPE and PET bottles used in prescription and over-the-counter drugs. The expansion also strengthens supply chain resilience amid increasing healthcare consumption.
- On July 9, 2025, AptarGroup Inc. introduced an integrated pharmaceutical bottle system combining dispensing closures and tamper-evident features to enhance medication safety and patient compliance. The solution is targeted at chronic disease therapies and hospital-use medications.
- On May 28, 2025, RPC Group (Berry Global subsidiary) reported increased adoption of pharmaceutical-grade plastic bottles across Europe, driven by regulatory shifts favoring lightweight, shatter-resistant alternatives to glass packaging in non-injectable drug formats.
Why Purchase the Report?
- Visualize the composition of the global pharmaceutical plastic bottle market segmentation by type, raw material, product type, capacity and region, highlighting the key commercial assets and players.
- Identify commercial opportunities in the global pharmaceutical plastic bottle market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of the global pharmaceutical plastic bottle market-level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global pharmaceutical plastic bottle market report would provide access to an approx. 69 market data table, 70 figures and 180 pages.
Target Audience 2026
- Manufacturers of Pharmaceutical Packaging
- Packaging Manufacturers
- Pharmaceutical Companies
- Traders, Distributors and Suppliers of Pharmaceutical Plastic Bottle
- Investment Research Firms
